Gelatinized immunomagnetic bead as well as preparation method and application thereof
A technology of immunomagnetic beads and gelation, which is applied in the direction of chemiluminescence/bioluminescence, analysis and measurement devices through chemical reactions of materials, and can solve the problems of self-crosslinking of antibodies, serious aggregation of immunomagnetic beads, and antibody grafting. It can improve the hydrophilicity, reduce the self-crosslinking of antibodies, and achieve good suspension.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0038] According to a typical embodiment of the present invention, a preparation method of gelled immunomagnetic beads is provided, such as figure 2 shown, including:
[0039] S1, reacting amino magnetic beads and gelatin under the action of a dianhydride organic acid anhydride initiator to obtain magnetic gelatin microspheres;
[0040] S2, using NHS solution, EDC solution and AEM to activate the magnetic gelatin microspheres to obtain a maleamidated magnetic gelatin microsphere solution;
[0041] S3, obtaining an activated antibody solution;
[0042] S4. Perform a coupling reaction between the maleamidated magnetic gelatin microsphere solution and the activated antibody solution to obtain a coupling reaction solution;
[0043] S5. Block the coupling reaction solution, then perform magnetic separation to obtain a solid, and resuspend the solid with a storage buffer to obtain gelled immunomagnetic beads.
[0044] A kind of gelling immune magnetic bead provided by the presen...
Embodiment 1
[0083] The chemiluminescence immunoassay kit in this embodiment includes R reagent and M reagent.
[0084] R reagent is the working solution prepared in advance, and the main component is alkaline phosphatase-labeled CTNI 1.
[0085] M reagent preparation process: Dilute the gelled immunomagnetic beads obtained in the embodiment of the present invention with M buffer solution into a working solution for later use, specifically:
[0086] (1) Solution preparation
[0087] Cross-linking buffer A: 100 mM pH 8.5 boric acid buffer.
[0088] Cross-linking buffer B: 100 mM pH 7.0 HEPES buffer.
[0089] Activator: use DMF (N,N dimethylformamide) to configure 20mg / ml initiator butane carboxylic acid dianhydride; use crosslinking buffer B to prepare 50mg / mL Sulfo-NHS and EDC·HCl; Configure 40mg / mL AEM in linking buffer B; configure 10mg / mL Traut's reagent in cross-linking buffer B. All activators need to be prepared and used immediately.
[0090] Blocking solution: 10% BSA.
[0091...
Embodiment 2
[0101] In Example 1, the initiator butane carboxylic dianhydride was replaced with cyclopentane tetracarboxylic dianhydride; the antibody was replaced with NT-proBNP2, and other components and processes were the same as in Example 1.
[0102] Control group 1
[0103] According to the synthesis method of immunomagnetic beads in CN108508195A, the antibody is replaced by CTNI2 antibody, and other processes and components remain unchanged.
[0104] Control group 2
[0105] According to the synthesis method of immunomagnetic beads in CN108508195A, the antibody is replaced by NT-proBNP2 antibody, and other processes and components remain unchanged.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com